clinical trial – Page 218 – Communicable Diseases Research

COVID-19: The Immune Responses and Clinical Therapy Candidates

Review

Published on 2020-08-032022-10-29
Journal: International Journal of Molecular Sciences [Category] COVID-19, MERS,

Corticosteroids on the Management of Coronavirus Disease 2019 (COVID-19): A Systemic Review and Meta-Analysis

Review Article

Published on 2020-08-012022-10-29
Journal: Iranian Journal of Public Health [Category] COVID-19,

Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption

Review article

Published on 2020-08-012022-10-05
Journal: Transfusion and apheresis science : official journ [Category] SARS, 치료법,

[키워드] Activation acute respiratory distress adaptive immune system alveolar edema approach Blood purification Blood purification therapies cause caused changes in clinical trial Complication COVID-19 Critically ill patient cytokine Cytokine storm dysregulation endotoxin extracorporeal blood purification functions hypercytokinemia hypoxia IL-6 immune response immune system immunopathological Inflammatory Inflammatory cytokines lung Lungs occur organ organ damage patients with COVID-19 Prevent PROTECT SARS-CoV-2 Sepsis sepsis-like syndrome shown Suppressing syndrome the cytokine storm therapy Treatment Vaccine Vaccines vascular leakage with COVID-19
[DOI] 10.1016/j.transci.2020.102855 [Article Type] Review article

Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities

Correspondence

Published on 2020-08-012022-10-05
Journal: Cancer treatment reviews [Category] SARS, 임상,

[키워드] activity affected clinical clinical trial clinical trials COVID-19 COVID-19 pandemic Drug development effective healthcare Healthcare system lesson measure oncology Patient recruitment reduce reduction resulting Therapies Treatment Trial virus
[DOI] 10.1016/j.ctrv.2020.102047 [Article Type] Correspondence

Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?

Research article

Published on 2020-08-012022-10-05
Journal: Archives of medical research [Category] SARS, 신약개발, 임상, 치료제,

Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment

Review article

Published on 2020-08-012022-10-05
Journal: Journal of the American Academy of Dermatology [Category] SARS, 치료법,

Optimising effectiveness of health care and value of clinical trials in the COVID -19 outbreak

Editorial

Published on 2020-08-012022-10-05
Journal: Pharmacological research [Category] SARS, 임상,

[키워드] Care clinical trial COVID Effectiveness Health Optimising outbreak
[DOI] 10.1016/j.phrs.2020.104993 [Article Type] Editorial

The COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges

코로나19 팬데믹과 GIMEMA 임상시험 관리: 변화와 도전

Article

Published on 2020-08-012022-09-11
Journal: British Journal of Haematology [Category] SARS, 임상,

[키워드] Abstract adult leukaemia change clinical trial clinical trials management COVID-19 COVID-19 pandemic GIMEMA management risk-based assessment survey
[DOI] 10.1111/bjh.16996 PMC 바로가기 [Article Type] Article

Food and COVID-19: Preventive/Co-therapeutic Strategies Explored by Current Clinical Trials and in Silico Studies

Review

Published on 2020-08-012022-11-01
Journal: Foods [Category] COVID-19,

COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature

Review article

Published on 2020-08-012022-10-05
Journal: Critical Reviews in Oncology/Hematology [Category] SARS, 치료제,

[키워드] ACE2angiotensin-converting enzyme 2 AIFAItalian Medicines Agency (Agenzia Italiana del Farmaco) androgen receptor signaling inhibitors angiotensin-converting enzyme 2 antineoplastic drugs ARSIandrogen receptor signaling inhibitors article Cancer cancer patient checkpoint inhibitors Chemotherapy Clinical practice clinical trial Colchicine conducted Corona Virus Disease Course COVID COVID 19 COVID-19 COVID-19 pandemic COVID-19corona virus disease CPIcheckpoint inhibitors CYPcytochrome P450 cytochrome P450 Dipeptidyl peptidase 4 disease disease-modifying antirheumatic drugs DMARDsdisease-modifying antirheumatic drugs DPP4Dipeptidyl peptidase 4 drug drug interaction Future highlight HIV-1human immunodeficiency virus Human immunodeficiency virus IL6Interleukin 6 Immunotherapy Inconclusive Interaction interleukin 6 Italian Medicines Agency (Agenzia Italiana del Farmaco) literature review oncologist positive provide Result ruxolitinib systematic review targeted therapy therapy Tocilizumab Treatment treatments for COVID-19
[DOI] 10.1016/j.critrevonc.2020.102991 [Article Type] Review article